⌘K

Login Start Free

Home/Filings/4/0000899243-21-006362

4//SEC Filing

Pienta Kenneth 4

Accession 0000899243-21-006362

CIK 0001645460other

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 5:52 PM ET

Size

5.4 KB

Accession

0000899243-21-006362

Insider Transaction Report

Form 4

Period: 2021-02-10

Cue Biopharma, Inc.CUE

Chief Medical Officer

Transactions

Award
Stock Option (right to buy)
2021-02-10+50,000→ 50,000 total
Exercise: $15.55Exp: 2031-02-09→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 10, 2021.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1

filerCIK 0001571862

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 5:52 PM ET
Size: 5.4 KB

View on SEC.gov